128 related articles for article (PubMed ID: 12056854)
1. Cardiomyocyte resistance to doxorubicin mediated by A(3) adenosine receptor.
Shneyvays V; Mamedova LK; Korkus A; Shainberg A
J Mol Cell Cardiol; 2002 May; 34(5):493-507. PubMed ID: 12056854
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damage.
Emanuelov AK; Shainberg A; Chepurko Y; Kaplan D; Sagie A; Porat E; Arad M; Hochhauser E
Biochem Pharmacol; 2010 Jan; 79(2):180-7. PubMed ID: 19686702
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist.
Shneyvays V; Nawrath H; Jacobson KA; Shainberg A
Exp Cell Res; 1998 Sep; 243(2):383-97. PubMed ID: 9743598
[TBL] [Abstract][Full Text] [Related]
4. Activation of A(3)adenosine receptor protects against doxorubicin-induced cardiotoxicity.
Shneyvays V; Mamedova L; Zinman T; Jacobson K; Shainberg A
J Mol Cell Cardiol; 2001 Jun; 33(6):1249-61. PubMed ID: 11444927
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes.
Wang GW; Klein JB; Kang YJ
J Pharmacol Exp Ther; 2001 Aug; 298(2):461-8. PubMed ID: 11454906
[TBL] [Abstract][Full Text] [Related]
6. Distinct KATP channels mediate the antihypertrophic effects of adenosine receptor activation in neonatal rat ventricular myocytes.
Xia Y; Javadov S; Gan TX; Pang T; Cook MA; Karmazyn M
J Pharmacol Exp Ther; 2007 Jan; 320(1):14-21. PubMed ID: 17012605
[TBL] [Abstract][Full Text] [Related]
7. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.
Sardão VA; Oliveira PJ; Holy J; Oliveira CR; Wallace KB
Cell Biol Toxicol; 2009 Jun; 25(3):227-43. PubMed ID: 18386138
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A1 receptor activation reduces opening of mitochondrial permeability transition pores in hypoxic cardiomyocytes.
Xiang F; Huang YS; Zhang DX; Chu ZG; Zhang JP; Zhang Q
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):343-9. PubMed ID: 19793110
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
Sun X; Zhou Z; Kang YJ
Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
[TBL] [Abstract][Full Text] [Related]
10. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E
Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin.
Solem LE; Heller LJ; Wallace KB
J Mol Cell Cardiol; 1996 May; 28(5):1023-32. PubMed ID: 8762040
[TBL] [Abstract][Full Text] [Related]
12. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
[TBL] [Abstract][Full Text] [Related]
13. Melatonin protection against lethal myocyte injury induced by doxorubicin as reflected by effects on mitochondrial membrane potential.
Xu M; Ashraf M
J Mol Cell Cardiol; 2002 Jan; 34(1):75-9. PubMed ID: 11812166
[TBL] [Abstract][Full Text] [Related]
14. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
15. The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis.
Frias MA; Somers S; Gerber-Wicht C; Opie LH; Lecour S; Lang U
Cardiovasc Res; 2008 Oct; 80(1):69-77. PubMed ID: 18567640
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity.
Khan M; Shobha JC; Mohan IK; Naidu MU; Sundaram C; Singh S; Kuppusamy P; Kutala VK
Phytother Res; 2005 Dec; 19(12):1030-7. PubMed ID: 16372368
[TBL] [Abstract][Full Text] [Related]
17. Analysis of calcium responses mediated by the A3 adenosine receptor in cultured newborn rat cardiac myocytes.
Shneyvays V; Zinman T; Shainberg A
Cell Calcium; 2004 Nov; 36(5):387-96. PubMed ID: 15451622
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
[TBL] [Abstract][Full Text] [Related]
19. Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes.
Germack R; Griffin M; Dickenson JM
J Mol Cell Cardiol; 2004 Nov; 37(5):989-99. PubMed ID: 15522276
[TBL] [Abstract][Full Text] [Related]
20. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
El-Demerdash E; Ali AA; Sayed-Ahmed MM; Osman AM
Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
